Nature Cancer

雜志介紹

Nature Cancer雜志介紹

《Nature Cancer》是一本以English為主的未開放獲取國際優秀期刊，中文名稱自然癌癥，本刊主要出版、報道醫學-ONCOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為23.5，最新CiteScore 指數為31.1。

本刊近期中國學者發表的論文主要有：

• A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-kappa B signaling

  Author: Altea-Manzano, Patricia; Doglioni, Ginevra; Liu, Yawen; Cuadros, Alejandro M.; Nolan, Emma; Fernandez-Garcia, Juan; Wu, Qi; Planque, Melanie; Laue, Kathrin Julia; Cidre-Aranaz, Florencia; Liu, Xiao-Zheng; Marin-Bejar, Oskar; Van Elsen, Joke; Vermeire, Ines; Broekaert, Dorien; Demeyer, Sofie; Spotbeen, Xander; Idkowiak, Jakub; Montagne, Aurelie; Demicco, Margherita; Alkan, H. Furkan; Rabas, Nick; Riera-Domingo, Carla; Richard, Francois; Geukens, Tatjana; De Schepper, Maxim; Leduc, Sophia; Hatse, Sigrid; Lambrechts, Yentl; Kay, Emily Jane; Lilla, Sergio; Alekseenko, Alisa; Geldhof, Vincent; Boeckx, Bram; de la Calle Arregui, Celia; Floris, Giuseppe; Swinnen, Johannes V.; Marine, Jean-Christophe; Lambrechts, Diether; Pelechano, Vicent; Mazzone, Massimiliano; Zanivan, Sara; Cools, Jan; Wildiers, Hans; Baud, Veronique; Gruenewald, Thomas G. P.; Ben-David, Uri; Desmedt, Christine; Malanchi, Ilaria; Fendt, Sarah-Maria

• A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAF(V600E) colorectal tumors

  Author: Ruiz-Saenz, Ana; Atreya, Chloe E.; Wang, Changjun; Pan, Bo; Dreyer, Courtney A.; Brunen, Diede; Prahallad, Anirudh; Munoz, Denise P.; Ramms, Dana J.; Burghi, Valeria; Spassov, Danislav S.; Fewings, Eleanor; Hwang, Yeonjoo C.; Cowdrey, Cynthia; Moelders, Christina; Schwarzer, Cecilia; Wolf, Denise M.; Hann, Byron; VandenBerg, Scott R.; Shokat, Kevan; Moasser, Mark M.; Bernards, Rene; Gutkind, J. Silvio; van 't Veer, Laura J.; Coppe, Jean-Philippe

• EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance

  Author: Chibaya, Loretah; Murphy, Katherine C. C.; DeMarco, Kelly D. D.; Gopalan, Sneha; Liu, Haibo; Parikh, Chaitanya N. N.; Lopez-Diaz, Yvette; Faulkner, Melissa; Li, Junhui; Morris, John P. P.; Ho, Yu-jui; Chana, Sachliv K. K.; Simon, Janelle; Luan, Wei; Kulick, Amanda; de Stanchina, Elisa; Simin, Karl; Zhu, Lihua Julie; Fazzio, Thomas G. G.; Lowe, Scott W. W.; Ruscetti, Marcus

• Disrupting the phase separation of KAT8-IRF1 diminishes PD-L1 expression and promotes antitumor immunity

  Author: Wu, Yuanzhong; Zhou, Liwen; Zou, Yezi; Zhang, Yijun; Zhang, Meifang; Xu, Liping; Zheng, Lisi; He, Wenting; Yu, Kuai; Li, Ting; Zhang, Xia; Chen, Zhenxuan; Zhang, Ruhua; Zhou, Penghui; Zhang, Nu; Zheng, Limin; Kang, Tiebang

英文介紹

Nature Cancer雜志英文介紹

Nature Cancer aims to publish the most significant advances across the full spectrum of cancer research in the life, physical, applied and social sciences, spanning basic preclinical, translational and clinical work. The journal’s broad scope covers all cancer research offering new insights into cancer biology, genetics and genomics, new approaches for the development and delivery of diagnostics and therapies, and new ways of understanding the global societal impact of cancer, thus ensuring that the work published reaches the widest possible audience.